ResMed, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jun'25
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,677.00
1,264.00
1,101.00
960.00
883.00
733.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
16.00
44.00
-462.00
-708.00
1.00
-97.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,751.00
1,401.00
693.00
351.00
736.00
802.00
Cash Flow from Investing Activities
-200.00
-269.00
-1,159.00
-229.00
-158.00
-179.00
Cash Flow from Financing Activities
-606.00
-1,119.00
422.00
-128.00
-764.00
-317.00
Net Cash Inflow / Outflow
971.00
10.00
-45.00
-21.00
-167.00
316.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
25.00
-1.00
-2.00
-14.00
18.00
10.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of ResMed, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
1677.566
585.287
1,092.00
186.62%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
16.738
-356.015
372.00
104.70%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1751.588
593.223
1,158.00
195.27%
Cash Flow from Investing Activities
-200.045
-112.445
-88.00
-77.90%
Cash Flow from Financing Activities
-606.253
-464.58
-142.00
-30.49%
Net Cash Inflow / Outflow
971.089
51.223
920.00
1795.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
25.799
35.025
-10.00
-26.34%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jun'25
YoY Growth in year ended Jun 2025 is 25.00% vs 102.11% in Jun 2024
Jun'25
Jun'24
Change(%)
Cash Flow from Operating Activities
1,751.59
1,401.26
25.00%






